嘉事堂(002462) - 2015 Q3 - 季度财报

Financial Performance - Operating revenue for the reporting period reached CNY 2,117,441,431.54, a 46.27% increase year-on-year[7] - Net profit attributable to shareholders was CNY 42,137,264.60, reflecting a 26.25% increase compared to the same period last year[7] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 41,074,749.48, up 23.33% year-on-year[7] - Basic earnings per share were CNY 0.18, an increase of 28.57% compared to the same period last year[7] - The weighted average return on equity was 3.08%, a decrease of 6.31% compared to the previous year[7] - Net profit attributable to the parent company decreased by CNY 61.73 million, a decrease of 31.89%, mainly due to non-operating income from the previous year[16] - The company expects a net profit attributable to shareholders for 2015 to decrease by 15% to 25%, estimating between RMB 17,043.36 million and RMB 19,478.13 million, compared to RMB 22,806.01 million in 2014[34] - The company anticipates a stable development of its various businesses, with a projected growth in net profit from main operations of 40% to 60%[34] Asset and Liability Changes - Total assets increased by 26.52% to CNY 5,753,167,237.20 compared to the end of the previous year[7] - Cash and cash equivalents increased by CNY 187.04 million, a growth of 41.65%, mainly due to the increase in the scope of consolidated subsidiaries and the recovery of sales payments[15] - Accounts receivable increased by CNY 858.82 million, a growth of 36.95%, primarily due to the rapid growth of newly acquired subsidiaries and the corresponding collection cycle[15] - Inventory increased by CNY 210.82 million, a growth of 31.42%, mainly due to the increase in the number of consolidated subsidiaries and the need for additional inventory reserves[15] - Short-term borrowings increased by CNY 685 million, a growth of 64.93%, primarily to supplement working capital[15] - Long-term deferred expenses increased by CNY 57.93 million, a growth of 195.41%, mainly due to the transfer of land lease fees for the Beijing logistics center project[15] Cash Flow and Investment Activities - The net cash flow from operating activities for the year-to-date was CNY -482,651,802.46, a decrease of 28.83%[7] - Investment activities generated a net cash outflow of CNY 243.67 million, a decrease of 483.88%, primarily due to payments for the acquisition of subsidiary equity[16] - Cash and cash equivalents net increase decreased by CNY 261.27 million, a decrease of 56.94%, mainly due to reduced cash flow from investment activities[16] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 14,187[10] - The largest shareholder, China Youth Industrial Development Corporation, held 17.45% of the shares[10] Acquisitions - The company acquired 51% of Guangzhou Jiashibai Medical Equipment Co., Ltd. for a total merger cost of RMB 48,795,474, with RMB 24,397,738 paid to date and the same amount pending[24] - The acquisition of 51% of Guangzhou Yihe Medical Technology Co., Ltd. had a total merger cost of RMB 38,598,841, with RMB 19,299,421 paid and the same amount still due[25] - The company purchased 51% of Shanghai Jiayi International Trade Co., Ltd. for a total of RMB 85,432,200, with RMB 42,716,100 paid and the same amount pending[26] - The acquisition of 51% of Zhejiang Jiashijiebo Medical Equipment Co., Ltd. totaled RMB 76,149,300, with RMB 38,074,650 paid and the same amount still due[27] - The company acquired 51% of Sichuan Xinxunhe Trading Co., Ltd. for a total of RMB 50,600,100, with RMB 25,300,050 paid and the same amount pending[28] - The acquisition of 51% of Chongqing Zhenyue Biotechnology Co., Ltd. had a total merger cost of RMB 38,919,900, with RMB 19,459,950 paid and the same amount still due[30]